Listed

EDGEWELL PERSONAL CARE Co: Form 10-Q for the period ended Dec 31, 2020

Filed with the SEC on Feb 9, 2021 and accepted by EDGAR at Feb 9, 2021, 13:10 ET.

Share

Management's discussion and analysis

As filed, 40,157 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

(in millions, except per share data, unaudited)

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited Condensed Consolidated Financial Statements and the accompanying notes included in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K filed with the SEC on November 20, 2020 (the “2020 Annual Report”). The following discussion may contain forward-looking statements that reflect our plans, estimates, and beliefs and involve risks, uncertainties, and assumptions. Our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to these differences include those discussed within “Forward-Looking Statements” below and in Item 1A. Risk Factors and “Forward-Looking Statements” included within our 2020 Annual Report.

Forward-Looking Statements

This document contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of Edgewell Personal Care Company (“Edgewell”, “we” or “our Company”) or any of our businesses. Forward-looking statements generally can be identified by the use of words or phrases such as “believe,” “expect,” “expectation,” “anticipate,” “may,” “could,” “intend,” “belief,” “estimate,” “plan,” “target,” “predict,” “likely,” “will,” “should,” “forecast,” “outlook,” or other similar words or phrases. These statements are not based on historical facts, but instead reflect our expectations, estimates, or projections concerning future results or events, including, without limitation, the future earnings and performance of our Company or any of our businesses. Many factors outside our control (including the ongoing COVID-19 pandemic) could affect the realization of these estimates. These statements are not guarantees of performance and are inherently subject to known and unknown risks, uncertainties and assumptions that are difficult to predict and could cause our actual results to differ materially from those indicated by those statements. We cannot assure you that any of our expectations, estimates or projections will be achieved. The forward-looking statements included in this report are only made as of the date of this report, and we disclaim any obligation to publicly update any forward-looking statement to reflect subsequent events or circumstances, except as required by law. You should not place undue reliance on these statements.

In addition, other risks and uncertainties not presently known to us or that we presently consider immaterial could significantly affect the forward-looking statements. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty. Risks and uncertainties include those detailed from time to time in our publicly filed documents, including in Item 1A. Risk Factors of Part I of our 2020 Annual Report.

Non-GAAP Financial Measures

While we report financial results in accordance with GAAP, this discussion also includes non-GAAP measures. These non-GAAP measures are referred to as “adjusted” or “organic” and exclude items such as restructuring costs, acquisition and integration costs, the gain on the sale of the Infant and Pet Care business, and the amortization of intangibles. Reconciliations of non-GAAP measures are included within this Management’s Discussion and Analysis of Financial Condition and Results of Operations.

This non-GAAP information is provided as a supplement to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP. We use this non-GAAP information internally to make operating decisions and believe it is helpful to investors because it allows more meaningful period-to-period comparisons of ongoing operating results. Given certain significant events, including the Project Fuel restructuring and recent acquisitions and divestitures, we view the use of non-GAAP measures that take into account the impact of these unique events as particularly valuable in understanding our underlying operational results and providing insights into future performance. The information can also be used to perform trend analysis and to better identify operating trends that may otherwise be masked or distorted by the types of items that are excluded. This non-GAAP information is also a component in determining management’s incentive compensation. Finally, we believe this information provides more transparency. The following provides additional detail on our non-GAAP measures:

  • We analyze our net sales and segment profit on an organic basis to better measure the comparability of results between periods. Organic net sales and organic segment profit exclude the impact of changes in foreign currency, acquisitions, and divestitures. This information is provided because these types of fluctuations can distort the underlying change in net sales and segment profit either positively or negatively.
  • Adjusted net earnings and adjusted earnings per share are defined as net earnings and diluted earnings per share excluding items such as restructuring costs, acquisition and integration costs, the gain on the sale of the Infant and Pet Care business, Feminine and Infant Care evaluation costs, and the related tax effects of these items.
  • Adjusted effective tax rate is defined as the effective tax rate excluding items such as restructuring costs, acquisition and integration costs, the gain on the sale of the Infant and Pet Care business, Feminine and Infant Care evaluation costs, and the related tax effects of these items from the income tax provision and earnings before income taxes.

All comparisons are with the same period in the prior year, unless otherwise noted.

Industry and Market Data

Unless we indicate otherwise, we base the information concerning our industry contained or incorporated by reference herein on our general knowledge of and expectations concerning the industry. Our market position, market share, and industry market size are based on our estimates using internal data and external data from various industry analyses, our internal research and adjustments, and assumptions that we believe to be reasonable. We have not independently verified data from industry analyses and cannot guarantee its accuracy or completeness. In addition, we believe that data regarding the industry, market size and our market position and market share within such industry provide general guidance but are inherently imprecise and have not been verified by any independent source. Further, our estimates and assumptions involve risks and uncertainties and are subject to change based on various factors, including those discussed in Item 1A. Risk Factors in Part I of our 2020 Annual Report. These, and other factors, could cause results to differ materially from those expressed in the estimates and assumptions. You are cautioned not to place undue reliance on this data.

Retail sales for purposes of market size, market position and market share information are based on retail sales in U.S. dollars.

Trademarks and Trade Names

We own or have rights to use trademarks and trade names that we use in conjunction with the operation of our business, which appear throughout this Quarterly Report on Form 10-Q. We may also refer to brand names, trademarks, service marks and trade names of other companies and organizations, and these brand names, trademarks, service marks and trade names are the property of their respective owners.

Impact of COVID-19

On March 11, 2020, the World Health Organization declared COVID-19 a worldwide pandemic, which has impacted individuals, families, companies and economies around the world. Due to the uncertainty surrounding COVID-19 and its fast spreading nature, we continue to take significant measures to protect our employees and business remaining in compliance with local guidelines and requirements. As a result of these COVID-19 related measures, we have incurred increased costs including increased employee costs, such as emergency pay and expanded benefits, and other operating costs, such as cleaning costs, personal protective equipment purchases and increased airfreight expenses, which have negatively impacted our profitability, partially offset by government credits provided to the Company through the CARES Act.

The Company’s top priority during this time continues to be ensuring the health and welfare of our employees. Additional measures have been put in place at all of our manufacturing locations to ensure the safety of our employees, including thermal scanning, requiring the use of proper protective gear, making hand sanitizer widely available throughout our facilities and following social distancing guidelines. Additionally, we have implemented work-from-home policies for our employees that can work from home and have cancelled all non-essential company travel. Despite increasing levels of absenteeism, we have not experienced any material operational disruption across our manufacturing and distribution facilities.

As noted within the discussion of our consolidated results below, our earnings were negatively impacted by the COVID-19 pandemic for the quarter ended December 31, 2020, which was largely driven by a decrease in demand for our Wet Shave and Sun Care products, impacted by stay-at-home orders and other restrictions. This decline was partially offset by an increase in demand for Wet Ones, due largely to consumers’ increased focus on personal hygiene. We expect to see continued strong demand for Wet Ones going forward. The impact that COVID-19 continues to have on our customers and their cash flows and ability to operate remains uncertain at this time. However, since the beginning of the pandemic we have in some cases seen minor changes in payment patterns, requests for extended payment terms or impact to customer operations, and thus have increased our allowance for doubtful accounts. As the duration and severity of the COVID-19 pandemic continues to affect economic conditions and therefore consumer spending and demand, we will continue to closely monitor the impact it has on our business and customers.

Additionally, the prolonged COVID-19 environment has resulted in increased supply chain challenges across product procurement and distribution. The continued duration and severity of COVID-19 may result in further disruptions related to our key suppliers going forward; however, the impact, timing and severity of potential disruptions cannot be reasonably estimated at this time.

We experienced increased volatility in foreign currency exchange rates and commodity prices in fiscal 2020 and the first quarter of fiscal 2021, which we believe is largely due to the economic uncertainty from COVID-19 and the depreciation of certain foreign currencies against the U.S. dollar. We expect to see continued volatility in foreign currency exchange rates; however, we cannot estimate the impact at this time.

We expect to maintain adequate liquidity during these uncertain times. As noted within “Liquidity and Capital Resources” below, COVID-19 has not had a significant impact on our liquidity, cash flows or capital resources, including our ability to enter into the unsecured indenture agreement for 5.50% Senior Notes in the amount of $750 due June 1, 2028 (“2028 Notes”), or to replace our former unsecured revolving credit facility in the U.S. with a new secured revolving credit facility in an aggregate principal amount of $425 (the “Revolving Credit Facility”). We will continue to assess the impact that COVID-19 has on our liquidity needs and the current economic market conditions.

Significant Events

Acquisitions

On September 2, 2020, the Company completed the acquisition of Cremo, a premier men's grooming company in the U.S, in an all-cash transaction at a purchase price of $233.9. As a result of the acquisition, Cremo became a wholly owned subsidiary of the Company. Refer to Note 2 of Notes to Condensed Consolidated Financial Statements for further discussion on the Cremo acquisition.

Divestiture

On December 17, 2019, we completed the sale of our Infant and Pet Care business included in the All Other segment for $122.5 which included consideration for providing services for up to one year under a transition services agreement. For further information on the divestiture of the Infant and Pet Care business, refer to Note 2 of Notes to Condensed Consolidated Financial Statements.

Executive Summary

The following is a summary of key results for the first quarter of fiscal 2021 compared to the first quarter of fiscal 2020. Net earnings and earnings per share (“EPS”) for the periods presented were impacted by restructuring charges, acquisition and integration costs, the gain on sale of Infant and Pet Care business, and Feminine and Infant Care evaluation costs, as described in the table below. The impact of these items on reported net earnings and EPS are provided as a reconciliation of net earnings and EPS to adjusted net earnings and adjusted diluted EPS, both of which are non-GAAP measures.

First Quarter of Fiscal 2021

  • Net sales in the first quarter of fiscal 2021 were $451.1, down 0.6% compared to the prior year quarter, inclusive of a 5.9% decline from the sale of the Infant and Pet Care business, a 3.7% increase due to the acquisition of Cremo and a 1.6% increase due to currency movements. Organic net sales were flat compared to the prior year quarter, due to declines in Wet Shave and Feminine Care, both of which have been impacted by decreased volumes that we believe were driven in part by COVID-19, and was partially offset by an increase in Sun and Skin Care from Wet Ones and Men’s Grooming products.
  • Net earnings in the first quarter of fiscal 2021 were $17.7 compared to $22.4 in the prior year quarter. On an adjusted basis, net earnings for the first quarter of fiscal 2021 decreased 22.1% to $23.3. Adjusted earnings were negatively impacted by the combined $3.7 in higher interest expense and lower other income, and a $2.2 net impact from acquisitions and divestitures, as compared to the prior year period.
  • Net earnings per diluted share during the first quarter of fiscal 2021 were $0.32 compared to $0.41 in the prior year quarter. On an adjusted basis, net earnings per diluted share during the first quarter of fiscal 2021 was $0.43 compared to $0.55 in the prior year quarter.
Three Months Ended December 31, 2020 Gross Profit SG&A Operating Income EBIT Income taxes Net Earnings Diluted EPS
GAAP — Reported $193.3 $93.1 $41.6 $25.2 $7.5 $17.7 $0.32
Restructuring and related costs 0.1 0.6 4.4 4.4 1.1 3.3 0.07
Acquisition and integration costs 1.3 1.7 3.0 3.0 0.7 2.3 0.04
Total Adjusted Non-GAAP $194.7 $90.8 $49.0 $32.6 $9.3 $23.3 $0.43
GAAP as a percent of net sales 42.9% 20.6% 9.2% GAAP effective tax rate 29.7%
Adjusted as a percent of net sales 43.2% 20.1% 10.9% Adjusted effective tax rate 28.4%
Three Months Ended December 31, 2019 Gross Profit SG&A Operating Income EBIT Income taxes Net Earnings Diluted EPS
GAAP — Reported $193.1 $95.0 $37.1 $29.6 $7.2 $22.4 $0.41
Restructuring and related costs — 1.9 8.0 8.0 1.7 6.3 0.13
Acquisition and integration costs — 6.2 6.2 6.2 1.6 4.6 0.08
Gain on sale of Infant and Pet Care business — — — (5.2) (1.6) (3.6) (0.07)
Feminine and Infant Care evaluation costs — 0.3 0.3 0.3 0.1 0.2 —
Total Adjusted Non-GAAP $193.1 $86.6 $51.6 $38.9 $9.0 $29.9 $0.55
GAAP as a percent of net sales 42.5% 20.9% 8.2% GAAP effective tax rate 24.4%
Adjusted as a percent of net sales 42.5% 19.1% 11.4% Adjusted effective tax rate 23.2%

25

Operating Results

The following table presents changes in net sales for the first quarter of fiscal 2021, as compared to the corresponding period in fiscal 2020, and provides a reconciliation of organic net sales to reported amounts.

Net Sales

Net Sales - Total Company Quarter Ended December 31, 2020 Q1 % Chg
Net sales - prior year $454.0
Organic — —%
Impact of Cremo acquisition 16.6 3.7%
Impact of the sale of the Infant and Pet Care business (26.8) (5.9)%
Impact of currency 7.3 1.6%
Net sales - current year $451.1 (0.6)%

For the first quarter of fiscal 2021, net sales were $451.1, a 0.6% decrease when compared with the prior year quarter. Organic net sales was flat compared to the prior year quarter. Organic net sales were flat, driven by growth in Wet Ones, Men’s Grooming, Women’s Systems and Private Label, offset by declines in Sun Care and Feminine Care. While COVID-19 continued to negatively impact the Wet Shave and Sun Care categories, the impact was partly mitigated by unanticipated higher demand in several International markets ahead of new, more stringent COVID-19 related lockdowns.

For further discussion regarding net sales, including a summary of reported versus organic changes, see “Segment Results.”

Gross Profit

Gross profit was $193.3 during the first quarter of fiscal 2021, as compared to $193.1 in the prior year quarter. Gross margin as a percent of net sales for the first quarter of fiscal 2020 was 42.9%, representing a 40-basis point increase over the prior year quarter gross margin percentage of 42.5%. Adjusted gross margin percentage increased 70-basis points driven primarily by Project Fuel savings, the positive impact of acquisitions and divestitures and lower cost of materials, partially offset by unfavorable product mix and pricing.

Selling, General and Administrative Expense

Selling, general and administrative expense (“SG&A”) was $93.1 in the first quarter of fiscal 2021, or 20.6% of net sales, as compared to $95.0 in the prior year quarter, or 20.9% of net sales. Adjusted SG&A as a percent of net sales increased 100-basis points, driven by general inflation, increased investments in the organization’s capabilities and higher equity compensation, partly off-set by lower travel and other discretionary spend and further Fuel savings.

Advertising and Sales Promotion Expense

For the first quarter of fiscal 2021, Advertising and sales promotion expense (“A&P”) was $41.2, up $0.1 compared to the prior year quarter A&P of $41.1. A&P spending as a percent of net sales was 9.1%, which is consistent with the prior year quarter. Increased spending in Men’s Grooming, Wet Ones and Wet Shave, was offset by lower spending in Sun Care. Both working dollars and digital spending increased compared to the prior year quarter.

Research and Development Expense

Research and development expense (“R&D”) for the first quarter of fiscal 2021 was $13.7, compared to $13.8 in the prior year quarter. As a percent of net sales, R&D was 3.0% in the first quarter of fiscal 2021 compared to 3.0% in the prior year quarter.

Interest Expense Associated with Debt

Interest expense associated with debt for the first quarter of fiscal 2021 was $17.4 compared to $14.3 in the prior year quarter. The increase in interest expense was the result of higher average outstanding debt and higher interest rate primarily as a result of the issuance of the 2028 Notes in May 2020.

Other Income, Net

Other income, net was $1.0 of income in the first quarter of fiscal 2021 compared to $1.6 in the prior year quarter. The decline in income was largely related to unfavorable foreign currency hedges and remeasurement income compared to the prior year quarter, partially offset by increased income in pension benefits.

Income Tax Provision

The effective tax rate for the first quarter of fiscal 2021 was 29.7% compared to 24.4% in the prior year period. On an adjusted basis, the effective tax rate was 28.4% and 23.2% for the first quarter of fiscal 2021 and fiscal 2020, respectively. Both the effective tax rate and adjusted effective tax rate reflects the unfavorable impact of US versus foreign earnings and the impact of the permanent adjustments related to 162(m).

The following table presents a reconciliation of the adjusted effective tax rate, which is a non-GAAP measure:

Three Months Ended December 31, 2020 Reported Adjustments (1) Adjusted (Non-GAAP) Three Months Ended December 31, 2019 Reported Adjustments (1) Adjusted (Non-GAAP)
Earnings before income taxes $25.2 $7.4 $32.6 $29.6 $9.3 $38.9
Income tax provision 7.5 1.8 9.3 7.2 1.8 9.0
Net earnings $17.7 $5.6 $23.3 $22.4 $7.5 $29.9
Effective tax rate 29.7% 24.4%
Adjusted effective tax rate 28.4% 23.2%

(1) Includes adjustments for expenses management excludes when analyzing the operating performance of the Company. Refer to the reconciliation of net earnings to adjusted net earnings for a detailed listing of adjustments.

Project Fuel

Project Fuel is an enterprise-wide transformational initiative that was launched in the second quarter of fiscal 2018 to address all aspects of our business and cost structure, simplifying and transforming our organization, structure and key processes. Project Fuel is facilitating further re-investment in our growth strategy while enabling us to achieve our desired future state operations.

In addition to the expected cost savings, Project Fuel is designed to strengthen our challenger culture and reinforce our consumer-centric organizational focus. It is also designed to simplify the organization and streamline ways of working in order to increase competitiveness, speed and agility, and ensure we have the skills, capabilities and investments needed to compete in a rapidly changing world.

We expect that Project Fuel will generate $265 to $275 in total annual gross savings by the end of the 2021 fiscal year. The savings generated will be used to fuel investments and brand building in strategic growth initiatives, offset anticipated operational cost headwinds from inflation and other rising input costs and improve our overall profitability and cash flows. Project Fuel related savings were approximately $16 for the three months ended December 31, 2020, bringing cumulative savings to $228 for the project.

To implement the restructuring element of Project Fuel, we expect to incur one-time pre-tax charges of approximately $160 to $165 through the end of the 2021 fiscal year. Restructuring and related charges were $4.4 for the three months ended December 31, 2020, bringing cumulative charges to $138.0 for the project.

Capital expenditures for Project Fuel were $1.8 for the three months ended December 31, 2020 bringing cumulative capital expenditures to $59.9 for the project.

For further information on our restructuring projects, refer to Note 3 of Notes to Condensed Consolidated Financial Statements.

Segment Results

The following tables present changes in segment net sales and segment profit for the first quarter of fiscal 2021, compared to the corresponding period in fiscal 2020, and provide a reconciliation of organic segment net sales and organic segment profit to reported amounts. For a reconciliation of segment profit to Earnings before income taxes, refer to Note 15 of Notes to Condensed Consolidated Financial Statements.

Our operating model includes some shared business functions across the segments, including product warehousing and distribution, transaction processing functions and, in most cases, a combined sales force and management teams. We apply a fully allocated cost basis in which shared business functions are allocated between the segments. As a result of the divestiture of the Infant and Pet Care business, some shared costs which were previously allocated to the All Other segment are now being allocated to the Wet Shave, Sun and Skin Care and Feminine Care segments, with the largest impact to Wet Shave, as noted in the discussion below.

Wet Shave

Net Sales - Wet Shave Quarter Ended December 31, 2020 Q1 % Chg
Net sales - prior year $277.0
Organic (4.2) (1.5)%
Impact of currency 6.3 2.3%
Net sales - current year $279.1 0.8%

Wet Shave net sales for the first quarter of fiscal 2021 increased 0.8% compared to the prior year quarter, inclusive of a 2.3% increase due to currency movements. Organic net sales decreased $4.2, or 1.5%, a significant sequential improvement, reflecting further stabilization of the business. Although COVID-19 continued to impact the category, and pricing and mix were unfavorable, volumes increased, largely driven by sales and market share gains in Women’s Systems, growth in Private Label across Men’s and Women’s, and improving trends in Men’s Systems. By region, North America organic net sales decreased 2.8% while International markets decreased 0.4%

Segment Profit - Wet Shave Quarter Ended December 31, 2020 Q1 % Chg
Segment profit - prior year $52.9
Organic (1.6) (3.0)%
Impact of currency 1.3 2.4%
Segment profit - current year $52.6 (0.6)%

Wet Shave segment profit for the first quarter of fiscal 2021 was $52.6, down $0.3, or 0.6%, compared to the prior year quarter, inclusive of the impact of currency movements. Excluding the impact of currency movements, organic segment profit decreased $1.6, or 3.0%, as slightly improved gross margin was offset by higher A&P for Women’s systems and Disposables during the quarter.

Sun and Skin Care

Sun and Skin Care segment net sales and profit are affected by the seasonality of sun care products. As a result, segment net sales and profit historically have been higher in the second and third quarters of the fiscal year.

Net Sales - Sun and Skin Care Quarter Ended December 31, 2020 Q1 % Chg
Net sales - prior year $75.1
Organic 10.5 14.0%
Impact of Cremo acquisition 16.6 22.1%
Impact of currency 0.8 1.1%
Net sales - current year $103.0 37.2%

Sun and Skin Care net sales for the first quarter of fiscal 2021 increased 37.2%, compared to the prior year quarter, inclusive of a 22.1% increase due to the Cremo acquisition and a 1.1% increase due to currency movements. Organic net sales increased $10.5, or 14.0%. Organic growth was driven by Wet Ones, increasing over 100%, and Men’s Grooming, which increased 12%. Sun Care net sales continued to be heavily impacted by COVID-19, declining 23% in the first quarter of fiscal 2021.

Segment Profit - Sun and Skin Care Quarter Ended December 31, 2020 Q1 % Chg
Segment profit - prior year $0.1
Organic 2.9 2,900.0%
Impact of Cremo acquisition 2.4 2,400.0%
Impact of currency (0.2) (200.0)%
Segment profit - current year $5.2 5,100.0%

Segment profit for the first quarter of fiscal 2021 was $5.2, an increase of $5.1 compared to the prior year quarter. Excluding the impact of the Cremo acquisition and currency movements, organic segment profit increased $2.9 driven by higher gross margin, reflecting higher volumes and favorable pricing, as well as reduced A&P spending in International Sun Care markets due to COVID-19.

Feminine Care

Net Sales - Feminine Care Quarter Ended December 31, 2020 Q1 % Chg
Net sales - prior year $75.1
Organic (6.3) (8.4)%
Impact of currency 0.2 0.3%
Net sales - current year $69.0 (8.1)%

Feminine Care net sales for the first quarter of fiscal 2021 decreased $6.1, or 8.1%, compared to the prior year quarter, inclusive of a 0.3% increase due to the impact of currency movements. The decline in net sales was largely driven by overall category declines, ongoing competitive pressure, and to the effect of distribution losses at Walmart.

Segment Profit - Feminine Care Quarter Ended December 31, 2020 Q1 %Chg
Segment profit - prior year $13.1
Organic (4.3) (32.8)%
Impact of currency — —%
Segment profit - current year $8.8 (32.8)%

29

Feminine Care segment profit for the first quarter of fiscal 2021 was $8.8, a decrease of $4.3, or 32.8% compared to the prior year quarter. The decline was driven by lower gross margin, reflecting lower volumes across all products and higher costs including materials cost and warehousing and distribution charges.

All Other

The Infant and Pet Care business divestiture completed in December 2019 disposed of the entirety of the operations of the All Other segment. The results below represent the impact of the divestiture to segment performance.

Net Sales - All Other Quarter Ended December 31, 2020 Q1 %Chg
Net sales - prior year $26.8
Organic — —%
Impact of the sale of the Infant and Pet Care business (26.8) (100.0)%
Impact of currency — —%
Net sales - current year $— (100.0)%
Segment Profit - All Other Quarter Ended December 31, 2020 Q1 %Chg
Segment profit - prior year $3.1
Organic — —%
Impact of the sale of the Infant and Pet Care business (3.1) (100.0)%
Impact of currency — —%
Segment profit - current year $— (100.0)%

General Corporate and Other Expenses

Quarter Ended December 31, 2020 2019
Corporate expenses $12.1 $13.3
Restructuring and related costs 4.4 8.0
Acquisition and integration costs 3.0 6.2
Gain on sale of Infant and Pet Care business — (5.2)
Feminine and Infant Care evaluation costs — 0.3
General corporate and other expenses $19.5 $22.6
% of net sales 4.3% 5.0%

For the first quarter of fiscal 2021, general corporate expenses were $12.1, or 2.7% of net sales, compared to $13.3, or 2.9% of net sales, in the prior year quarter. For the first quarter of fiscal 2021, the decline in corporate expense relates to Project Fuel savings and lower discretionary spending partially offset by higher deferred compensation and other benefit expenses.

Liquidity and Capital Resources

To date, COVID-19 has not had a significant impact on our liquidity or capital resources. However, the continued spread of COVID-19 has led to disruption and volatility in the global capital markets, which, depending on future developments, could impact our capital resources and liquidity in the future.

At December 31, 2020, a portion of our cash balances were located outside the U.S. Given our extensive international operations, a significant portion of our cash is denominated in foreign currencies. We manage our worldwide cash requirements by reviewing available funds among the many subsidiaries through which we conduct business and the cost effectiveness with which those funds can be accessed. We generally repatriate a portion of current year earnings from select non-U.S. subsidiaries only if the economic cost of the repatriation is not considered material.

The counterparties that hold our deposits consist of major financial institutions. We consistently monitor positions with, and credit ratings of, counterparties both internally and by using outside ratings agencies.

Our total borrowings were $1,274.1 at December 31, 2020 including $24.1 tied to variable interest rates. Our total borrowings at September 30, 2020 were $1,271.1. The 4.70% Senior Notes in the amount of $500 mature in May 2022. We expect to refinance prior to maturity.

We had outstanding international borrowings, recorded in Notes payable, of $24.1 and $21.1 as of December 31, 2020 and September 30, 2020, respectively.

Historically, we have generated and expect to continue to generate positive cash flows from operations. Our cash flows are affected by the seasonality of our Sun Care products, typically resulting in higher net sales and increased cash generated in the second and third quarter of each fiscal year. While we cannot reasonably estimate the full impact COVID-19 will have on our cash flows, we believe our cash on hand, cash flows from operations and borrowing capacity under the Revolving Credit Facility will be sufficient to satisfy our future working capital requirements, interest payments, research and development activities, capital expenditures, and other financing requirements for at least the next 12 months. We will continue to monitor our cash flows, spending and liquidity needs.

Short-term financing needs primarily consist of working capital requirements and principal and interest payments on our long-term debt. Long-term financing needs will depend largely on potential growth opportunities, including acquisition activity and repayment or refinancing of our long-term debt obligations. We may, from time-to-time, seek to repurchase shares of our common stock. Such repurchases, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. Our long-term liquidity may be influenced by our ability to borrow additional funds, renegotiate existing debt, and raise equity under terms that are favorable to us.

The expected minimum required contribution to our pension plans in fiscal 2021 is $6.3; however, discretionary contributions may also be made. During the first quarter of fiscal 2021 we contributed $1.2 to our pension plans.

As of December 31, 2020, we were in compliance with the provisions and covenants associated with our debt agreements.

Cash Flows

A summary of our cash flow activities is provided in the following table:

Net cash from (used by): Three Months Ended December 31, 2020 2019
Operating activities $(82.5) $(46.9)
Investing activities (2.3) 89.7
Financing activities (5.5) (135.9)
Effect of exchange rate changes on cash 6.4 3.3
Net decrease in cash and cash equivalents $(83.9) $(89.8)

31

Operating Activities

Cash flow used by operating activities was $82.5 during the first quarter of fiscal 2021, compared to $46.9 during the same period in the prior year. The increase in cash used by operating cash flows was primarily related to changes in working capital, driven by higher inventory levels, the timing of collections and higher payments on accrued liabilities including higher debt interest payments.

Investing Activities

Cash flow used by investing activities was $2.3 during the first quarter of fiscal 2021, compared to cash inflows of $89.7 during the same period in the prior year. During the three months ended December 31, 2020, we collected $7.5 of proceeds from the sale of the Infant and Pet Care business compared to $95.8 in the prior year quarter. Capital expenditures were $10.2 during the first three months of fiscal 2021 compared to $7.6 during the same period in the prior year. Additionally, other investing cash inflows related to the collection of receivables from the $150 uncommitted master accounts receivable purchase agreement with The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the purchaser (“Accounts Receivable Facility”) totaled $1.5 and $2.8 during the first three months of fiscal 2021 and 2020, respectively, as a result of collections on the deferred purchase price of accounts receivables sold.

Financing Activities

Net cash used by financing activities was $5.5 during the first quarter of fiscal 2021, compared to $135.9 during the same period in the prior year. During the first three months of fiscal 2021, we repurchased $9.2 of our common stock under the Board authorized share repurchase plan. Additionally, cash flows associated with the Accounts Receivable Facility were inflows of $4.2 during the first three months of fiscal 2021 compared to financing outflows of $14.9 in the prior year period. During the first three months of fiscal 2020, we had financing outflows for repayments of the U.S. revolving credit facility due 2020 of $117.0.

Share Repurchases

During the first three months of fiscal 2021, we repurchased 0.3 shares of our common stock for $9.2. We have 9.7 shares remaining under the existing Board authorization to repurchase our common stock. Future share repurchases, if any, would be made in the open market, privately negotiated transactions or otherwise, in such amounts and at such times as we deem appropriate based upon prevailing market conditions, business needs and other factors.

Dividends

On November 20, 2020, our Board of Directors declared a cash dividend of $0.15 per share of common stock outstanding, payable on January 6, 2021 to holders of record as of the close of business on December 10, 2020. Dividends declared during the three months ended December 31, 2020 totaled $8.5. There were no dividend payments made during the three months ended December 31, 2020.

On February 9, 2021, our Board of Directors declared a cash dividend of $0.15 per share of common stock outstanding, payable April 6, 2021 to holders of record as of the close of business on March 5, 2021.

Commitments and Contingencies

Contractual Obligations

During the first three months of fiscal 2021, there were no net repayments on the Revolving Credit Facilities. As of December 31, 2020, future minimum repayments of debt were: $500.0 in fiscal 2022 and $750.0 in fiscal 2028.

There have been no other material changes in our contractual obligations since the presentation in our 2020 Annual Report.

Supplemental Guarantor Financial Information

In 2012,we issued 4.70% Senior Notes in the amount of $500 due May 24, 2022 (“2022 Notes”), which are fully and unconditionally guaranteed on a joint and several basis by the Company’s existing and future material direct and indirect domestic subsidiaries that are guarantors of any the Company’s credit agreements or other indebtedness for borrowed money (the “Guarantors”). The Guarantors are 100% owned either directly or indirectly by the Company and jointly and severally guarantee the Company’s obligations under the 2022 Notes. The Company’s subsidiaries organized outside of the U.S. and certain domestic subsidiaries which are not guarantors of any of the Company’s other indebtedness (collectively, the “Non-Guarantors”), do not guarantee the 2022 Notes. The subsidiary guarantee with respect to the 2022 Notes is subject to release upon sale of all of the capital stock of the subsidiary guarantor; if the guarantee under the Company’s credit agreements and other indebtedness for borrowed money is released or discharged (other than due to payment under such guarantee); or when the requirements for legal defeasance are satisfied or the obligations are discharged in accordance with the indenture.

The following tables present summarized financial information for the Parent and the Guarantors on a combined basis after elimination of (i) intercompany transactions and balances among the Parent and the Guarantors and (ii) equity in earnings from and investments in any subsidiary that is a non-Guarantor.

Summarized Statement of Operations Three Months Ended December 31, 2020
Net sales $292.5
Gross profit 107.5
Net loss (7.8)
Summarized Balance Sheet Assets December 31, 2020 September 30, 2020
Current assets $368.8 $419.1
Non-current assets 1,934.6 1,947.4
Liabilities and Shareholder’s Equity
Current liabilities 247.1 283.4
Non-current liabilities 1,517.6 1,517.1

33

Market risk

As filed, 1,202 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The market risk inherent in our financial instruments and positions represents the potential loss arising from adverse changes in currency rates, commodity prices, and interest rates. At times, we enter into contractual arrangements (derivatives) to reduce these exposures. For further information on our foreign currency derivative instruments, refer to Note 14 of Notes to Condensed Consolidated Financial Statements. As of December 31, 2020, there were no open derivative or hedging instruments for future purchases of raw materials or commodities. Our exposure to interest rate risk relates primarily to our variable-rate debt instruments, which currently bear interest based on LIBOR plus margin. As of December 31, 2020, our outstanding variable-rate debt included $24.1 related to our international, variable-rate note payable. Assuming a one-percent increase in the applicable interest rates, annual interest expense on these variable-rate debt instruments would not increase materially.

There have been no material changes in our assessment of market risk sensitivity since our presentation of Quantitative and Qualitative Disclosures About Market Risk in our 2020 Annual Report on Form 10-K.

Controls and procedures

As filed, 1,203 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the specified time periods, and that such information is accumulated and communicated to management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate, to allow timely decisions regarding required disclosure.

Our management, with the participation of our CEO and CFO, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31, 2020. Based on that evaluation, our CEO and CFO concluded that, as of that date, our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended December 31, 2020 that have materially affected, or are likely to materially affect, our internal control over financial reporting.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-10-01 to 2020-12-31$451.1mus-gaap:Revenues
Cost of revenue3 months2020-10-01 to 2020-12-31$257.8mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2020-10-01 to 2020-12-31$193.3mus-gaap:GrossProfit
Research and development3 months2020-10-01 to 2020-12-31$13.7mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2020-10-01 to 2020-12-31$93.1mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2020-10-01 to 2020-12-31$41.6mus-gaap:OperatingIncomeLoss
Interest expense3 months2020-10-01 to 2020-12-31$17.4mus-gaap:InterestExpense
Income tax3 months2020-10-01 to 2020-12-31$7.5mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-10-01 to 2020-12-31$17.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-10-01 to 2020-12-31$0.32us-gaap:EarningsPerShareDiluted
Basic EPS3 months2020-10-01 to 2020-12-31$0.33us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2020-10-01 to 2020-12-3154,800,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2020-10-01 to 2020-12-31−$82.5mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2020-10-01 to 2020-12-31$10.2mus-gaap:PaymentsToAcquireProductiveAssets
Share repurchases3 months2020-10-01 to 2020-12-31$9.2mus-gaap:PaymentsForRepurchaseOfCommonStock
Current assetsAt period end2020-12-31$933.4mus-gaap:AssetsCurrent
Total assetsAt period end2020-12-31$3.50bnus-gaap:Assets
Current liabilitiesAt period end2020-12-31$428.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-12-31$2.03bnus-gaap:Liabilities
Long-term debtAt period end2020-12-31$1.24bnus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2020-12-31$1.47bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001096752-21-000009. Last ingested by Listed: Nov 14, 2026, 23:53 ET. Listed shows no prices and gives no investment advice.